Initial chemotherapy dose reductions and subsequent treatment delivery in stage I-IIIA breast cancer.

Key Points

• This research examines how initial dose reductions in chemotherapy affect later treatment delivery in breast cancer patients.
• Analyzed chemotherapy dosing decisions among patients with stage I-IIIA breast cancer.
• Monitored the consistency of dosing following initial treatment.
• Evaluated the relationship between dose reductions and subsequent treatment adjustments.
• Most patients who started with full chemotherapy doses maintained consistent dosing throughout treatment.
• Early dose reductions did not prevent further changes in treatment delivery.
• Highlights the importance of balancing safety with maintaining adequate dosing intensity.